We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Illumina Announces Scale-Up of its Genome Analyzer Sequencing Technology at the Broad Institute
News

Illumina Announces Scale-Up of its Genome Analyzer Sequencing Technology at the Broad Institute

Illumina Announces Scale-Up of its Genome Analyzer Sequencing Technology at the Broad Institute
News

Illumina Announces Scale-Up of its Genome Analyzer Sequencing Technology at the Broad Institute

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Illumina Announces Scale-Up of its Genome Analyzer Sequencing Technology at the Broad Institute"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Illumina, Inc. has announced that the Broad Institute of MIT and Harvard has acquired 22 additional Genome Analyzers to increase its installed base of the Illumina sequencing platform to 47 units.

"We are excited to build on our strong relationship with Illumina," said Eric S. Lander, Director of the Broad Institute of MIT and Harvard. "We also believe that this partnership will help accelerate the application of genomics to medical practice."

"The Broad Institute's decision to significantly scale their installed base of Genome Analyzers is a tremendous sign of their confidence in our ability to continue improving the performance and economics of the system," said Christian Henry, Senior Vice President and Chief Financial Officer at Illumina.

Over the course of the year Illumina plans to increase the throughput of the Genome Analyzer to as much as 95 gigabases of highly accurate DNA sequence data per single run, or the equivalent of one whole human genome at 30 times coverage.

Designed for facilities of all sizes, the Illumina Genome Analyzer has been adopted across genome centers worldwide, plus individual research labs, core and service facilities, and biotechnology and pharmaceutical companies.

The Genome Analyzer also offers the broadest set of supported applications, including those used to profile and discover novel transcripts, to create a high-resolution genome-wide map of DNA-protein binding sites and to sequence entire human genomes to greater than 30x coverage.
Advertisement